Prognostic factors in young patients with ST-segment elevation myocardial infarction.
Journal
Coronary artery disease
ISSN: 1473-5830
Titre abrégé: Coron Artery Dis
Pays: England
ID NLM: 9011445
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
14
7
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
The prognostic factors of young patients aged ≤40 years with ST-segment elevation myocardial infarction (STEMI) remain unclear. This study explored risk factors that may affect the 1-year prognosis of young STEMI patients by analyzing patient data of baseline, clinical regimen, and secondary prevention. Baseline and clinical data were collected from 420 STEMI patients aged ≤40 years. One year of follow-up was performed to record and compare the differences in data between patients with and without adverse events. Binary logistic regression analysis with controls for confounding factors was used to evaluate prognosis-related independent factors. The overall incidence of cardiovascular adverse events was 15.95%. Comparison of the subgroups revealed that regardless of adjustment for confounding factors, prognoses of the patients were affected by the following factors: BMI, marital status, serum apolipoprotein(a) (ApoA) levels, number of diseased vessels, treatment regimen, compliance of secondary prevention, improvement of lifestyle, and adjusted comorbidities ( P < 0.05). Independent analysis of adverse events revealed that BMI, number of diseased vessels, and compliance of secondary prevention were independent factors of recurrent acute myocardial infarction in patients. Serum ApoA level, treatment regimen, and compliance of secondary prevention were independent influence factors of heart failure in patients. Marital status and serum ApoA level were independent factors of malignant arrhythmias in patients. BMI, compliance of secondary prevention, and improvement of lifestyle were independent factors of cardiac death in patients. This study determined the influential factors for the prognosis of STEMI patients aged ≤40 years as follows: BMI, marital status, comorbidities, number of diseased vessels, regimen, compliance of secondary prevention, and improvement of lifestyle. The risk of cardiovascular adverse events may be reduced by modulating the influential factors.
Identifiants
pubmed: 37335221
doi: 10.1097/MCA.0000000000001260
pii: 00019501-202308000-00002
doi:
Substances chimiques
Apolipoproteins A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
298-305Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Soares GP. Analysis of a population-based registry of hospitalizations for acute myocardial infarction. Arq Bras Cardiol 2020; 115:925–926.
Akbar H, Foth C, Kahloon RA, Mountfort S. Acute ST elevation myocardial infarction. StatPearls Publishing LLC.; 2022.
Zhong Q, Gao Y, Zheng X, Chen J, Masoudi FA, Lu Y, et al. Geographic variation in process and outcomes of care for patients with acute myocardial infarction in China from 2001 to 2015. JAMA Netw Open 2020; 3:e2021182.
Xu H, Yang Y, Wang C, Yang J, Li W, Zhang X, et al.; China Acute Myocardial Infarction Registry Investigators. Association of hospital-level differences in care with outcomes among patients with acute ST-segment elevation myocardial infarction in China. JAMA Netw Open 2020; 3:e2021677.
Pletcher MJ, Moran AE. Cardiovascular risk assessment. Med Clin North Am 2017; 101:673–688.
The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci 2022; 35:573–603.
The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2019: an updated summary. Chin Circ J 2020; 35:833–854.
Li J, Dharmarajan K, Bai X, Masoudi FA, Spertus JA, Li Xi, et al. Thirty-day hospital readmission after acute myocardial infarction in China. Circ Cardiovasc Qual Outcomes 2019; 12:e005628.
Lv J, Ni L, Liu K, Gao X, Yang J, Zhang X, et al. Clinical characteristics, prognosis, and gender disparities in young patients with acute myocardial infarction. Front Cardiovasc Med 2021; 8:720378.
Yanase T, Sakakura K, Taniguchi Y, Yamamoto K, Tsukui T, Seguchi M, et al. Comparison of clinical characteristics of acute myocardial infarction between young (<55 years) and older (55 to <70 years) patients. Int Heart J 2021; 62:33–41.
Liu H, Zhang J, Ma Z, Xu Z. Clinical study on characteristics and risk factors of coronary artery lesions in young patients with acute myocardial infarction. Evid Based Complement Alternat Med 2021; 2021:5716410.
Doll JA, Hellkamp AS, Thomas L, Fonarow GC, Peterson E, Wang TY. The association of pre- and posthospital medication adherence in myocardial infarction patients. Am Heart J 2019; 208:74–80.
Mathews R, Wang W, Kaltenbach LA, Thomas L, Shah RU, Ali M, et al. Hospital variation in adherence rates to secondary prevention medications and the implications on quality. Circulation 2018; 137:2128–2138.
Lee YM, Kim RB, Lee HJ, Kim K, Shin M-H, Park H-K, et al. Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study. Health Qual Life Outcomes 2018; 16:100.
Alexander T, Kumbhani DJ, Subban V, Sundar H, Nallamothu BK, Mullasari AS. Acute ST-elevation myocardial infarction in the young compared with older patients in the Tamil Nadu STEMI program. Heart Lung Circ 2021; 30:1876–1882.
Lisowska A, Makarewicz-Wujec M, Filipiak KJ. Risk factors, prognosis, and secondary prevention of myocardial infarction in young adults in Poland. Kardiol Pol 2016; 74:1148–1153.
Barroso M, Goday A, Ramos R, Marín-Ibañez A, Guembe MJ, Rigo F, et al.; FRESCO Investigators. Interaction between cardiovascular risk factors and body mass index and 10-year incidence of cardiovascular disease, cancer death, and overall mortality. Prev Med 2018; 107:81–89.
Joyce E, Hoogslag GE, Kamperidis V, Debonnaire P, Katsanos S, Mertens B, et al. Relationship between myocardial function, body mass index, and outcome after ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging 2017; 10:e005670.
Zamanian-Daryoush M, DiDonato JA. Apolipoprotein A-I and cancer. Front Pharmacol 2015; 6:265.
Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Lamon D, et al. Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. PLoS One 2013; 8:e77211.
Gibson CM, Kastelein JJP, Phillips AT, Aylward PE, Yee MK, Tendera M, et al. Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. Am Heart J 2021; 231:121–127.
Xiong D, Yang T, Zhang Q, Chen L, Liu A. Clinical characteristics of young patients with acute myocardial infarction. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014; 39:361–364.
Zasada W, Bobrowska B, Plens K, Dziewierz A, Siudak Z, Surdacki A, et al. Acute myocardial infarction in young patients. Kardiol Pol 2021; 79:1093–1098.
Singh B, Singh A, Goyal A, Chhabra S, Tandon R, Aslam N, et al. The prevalence, clinical spectrum and the long term outcome of ST-segment elevation myocardial infarction in young – a prospective observational study. Cardiovasc Revasc Med 2019; 20:387–391.
Berntson J, Patel JS, Stewart JC. Number of recent stressful life events and incident cardiovascular disease: moderation by lifetime depressive disorder. J Psychosom Res 2017; 99:149–154.
Roth L, Rombouts M, Schrijvers DM, Lemmens K, De Keulenaer GW, Martinet W, et al. Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice. Atherosclerosis 2015; 242:288–294.
Franquesa M, Pujol-Busquets G, García-Fernández E, Rico L, Shamirian-Pulido L, Aguilar-Martínez A, et al. Mediterranean diet and cardiodiabesity: a systematic review through evidence-based answers to key clinical questions. Nutrients 2019; 11:655.
Deng W, Li Le, Wang Z, Chang X, Li R, Fang Z, et al. Using AGREE II to evaluate the quality of traditional medicine clinical practice guidelines in China. J Evid Based Med 2016; 9:152–162.